Braidwell LP

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
64
Total Value
2844802567
Accession Number
0001420506-25-001293
Form Type
13F-HR
CIK
0001920938
Manager Name
Braidwell LP
Data Enrichment
75% identified
48 identified16 unidentified

Holdings

64 positions
Manager:
SEC
Search and click to pin securities to the top
Page 3 of 4
252131AM9
252131AM9
Shares:
0
Value:
$22.8B(-69.3%)
MARAVAI LIFESCIENCES HOLDINGS, INC.
MRVI|56600D107
Shares:
8353287(+0.0%)
Value:
$18.5B(-59.4%)
252131AK3
252131AK3
Shares:
0
Value:
$18.0B(+0.9%)
Xencor Inc
XNCR|98401F105
Shares:
1655690(+169.0%)
Value:
$17.6B(+24.5%)
Ascendis Pharma A/S
ASND|04351P101
Shares:
106713
Value:
$16.6B
Oruka Therapeutics, Inc.
ORKA|687604108
Shares:
1572426(+37.0%)
Value:
$16.1B(-40.5%)
MADRIGAL PHARMACEUTICALS, INC.
MDGL|558868105
Shares:
48690
Value:
$16.1B
Sarepta Therapeutics, Inc.
SRPT|803607100
Shares:
234500(-35.7%)
Value:
$15.0B(-66.3%)
Replimune Group, Inc.
REPL|76029N106
Shares:
1461826(-1.0%)
Value:
$14.3B(-20.3%)
REPLIGEN CORP
RGEN|759916109
Shares:
81656(-71.2%)
Value:
$10.4B(-74.6%)
IRONWOOD PHARMACEUTICALS INC
IRWD|46333X108
Shares:
6622584(+21.7%)
Value:
$9.7B(-59.6%)
Celcuity Inc.
CELC|15102K100
Shares:
884306(+0.0%)
Value:
$8.9B(-22.8%)
Cullinan Therapeutics, Inc.
CGEM|230031106
Shares:
980773(-16.6%)
Value:
$7.4B(-48.2%)
CASTLE BIOSCIENCES INC
CSTL|14843C105
Shares:
365247
Value:
$7.3B
Dianthus Therapeutics, Inc. /DE/
DNTH|252828108
Shares:
375355(-68.9%)
Value:
$6.8B(-74.1%)
02081GAB8
02081GAB8
Shares:
0
Value:
$5.8B(-89.5%)
Pulmonx Corp
LUNG|745848101
Shares:
752541(+0.0%)
Value:
$5.1B(-0.9%)
59267L107
59267L107
Shares:
175000
Value:
$4.8B
002942100
002942100
Shares:
500000
Value:
$3.8B
008064107
008064107
Shares:
1440499(+0.0%)
Value:
$3.6B(-5.3%)